Clinical trial
Treatment of Plantar Fasciitis With Xeomin: A Randomized, Placebo-Controlled, Double-Blinded, Prospective Study
NCT01678001 is registered in ClinicalTrials.gov with Rothman Institute Orthopaedics as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Treatment of Plantar Fasciitis With Xeomin: A Randomized, Placebo-Controlled, Double-Blinded, Prospective Study
- Lead sponsor
- Rothman Institute Orthopaedics
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- August 31, 2012
- Completion date
- August 31, 2016
- Enrollment
- 50 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
plantar fascitis